Dickson ER - Search Results

1

Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease.

Kim WR, Lindor KD, Malinchoc M, Petz JL, Jorgensen R, Dickson ER. Kim WR, et al. Among authors: dickson er. Hepatology. 2000 Nov;32(5):924-9. doi: 10.1053/jhep.2000.19067. Hepatology. 2000. PMID: 11050040

2

Hypercholesterolemia and atherosclerosis in primary biliary cirrhosis: what is the risk?

Crippin JS, Lindor KD, Jorgensen R, Kottke BA, Harrison JM, Murtaugh PA, Dickson ER. Crippin JS, et al. Among authors: dickson er. Hepatology. 1992 May;15(5):858-62. doi: 10.1002/hep.1840150518. Hepatology. 1992. PMID: 1568727 Clinical Trial.

3

The metabolic bone disease of primary sclerosing cholangitis.

Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF. Hay JE, et al. Among authors: dickson er. Hepatology. 1991 Aug;14(2):257-61. Hepatology. 1991. PMID: 1860683

4

The autologous mixed lymphocyte reaction in primary biliary cirrhosis: analysis of activation and blastogenesis of autoreactive T lymphocytes.

Lindor KD, Wiesner RH, Dickson ER, Homburger HA. Lindor KD, et al. Among authors: dickson er. Hepatology. 1988 Nov-Dec;8(6):1555-9. doi: 10.1002/hep.1840080614. Hepatology. 1988. PMID: 3263933

5

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.

Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP. Lindor KD, et al. Among authors: dickson er. Hepatology. 1995 Oct;22(4 Pt 1):1158-62. doi: 10.1016/0270-9139(95)90624-x. Hepatology. 1995. PMID: 7557866 Clinical Trial.

6

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

Lindor KD, Janes CH, Crippin JS, Jorgensen RA, Dickson ER. Lindor KD, et al. Among authors: dickson er. Hepatology. 1995 Feb;21(2):389-92. Hepatology. 1995. PMID: 7843710 Clinical Trial.

7

Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression.

Van Norstrand MD, Malinchoc M, Lindor KD, Therneau TM, Gershwin ME, Leung PS, Dickson ER, Homburger HA. Van Norstrand MD, et al. Among authors: dickson er. Hepatology. 1997 Jan;25(1):6-11. doi: 10.1002/hep.510250103. Hepatology. 1997. PMID: 8985257

8

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.

Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, Krom RA, Wiesner RH, Lindor KD. Kim WR, et al. Among authors: dickson er. Hepatology. 1997 Jul;26(1):22-6. doi: 10.1002/hep.510260103. Hepatology. 1997. PMID: 9214447 Clinical Trial.

9

Cost-effectiveness of ursodeoxycholic acid therapy in primary biliary cirrhosis.

Pasha T, Heathcote J, Gabriel S, Cauch-Dudek K, Jorgensen R, Therneau T, Dickson ER, Lindor KD. Pasha T, et al. Among authors: dickson er. Hepatology. 1999 Jan;29(1):21-6. doi: 10.1002/hep.510290116. Hepatology. 1999. PMID: 9862844 Clinical Trial.

10

Quality of life before and after liver transplantation for cholestatic liver disease.

Gross CR, Malinchoc M, Kim WR, Evans RW, Wiesner RH, Petz JL, Crippin JS, Klintmalm GB, Levy MF, Ricci P, Therneau TM, Dickson ER. Gross CR, et al. Among authors: dickson er. Hepatology. 1999 Feb;29(2):356-64. doi: 10.1002/hep.510290229. Hepatology. 1999. PMID: 9918910

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters